| Field | Value |
|---|---|
| Data last updated | August 17, 2023 |
| Metadata last updated | August 17, 2023 |
| Created | August 17, 2023 |
| Format | CSV |
| License | Open Government Licence 3.0 (United Kingdom) |
| Column | Title | Type | Description |
|---|---|---|---|
| ODS_CODE | Organisation Data Service code for pharmacy, appliance, or local pharmaceutical services contractor | string | The Organisation Data Service (ODS) code of the premises at which pharmaceutical services may be provided |
| PHARMACY_NAME | Trading name of contractor | string | The name under which a pharmacy contractor, appliance contractor, or local pharmaceutical services contractor trades |
| ICB_NAME | Integrated Care Board (ICB) Name | string | The name given to a geographical statutory organisation by NHS England that is a smaller division of a region |
| ICB_CODE | Integrated Care Board (ICB) Code | string | The unique code used to refer to an ICB |
| Q1 | A question asked whilst completing the quality domain in the PQS declaration on MYS | string | Do you declare that you will have a new written safety report, available for inspection at premises level, by the end of 31 March 2023? Answers: yes / no Mandatory |
| Q2 | A question asked whilst completing the quality domain in the PQS declaration on MYS | string | Do you declare that demonstrable learnings from a review of all patient safety incidents will have been incorporated into the safety report by the end of 31 March 2023? Answers: yes / no Mandatory |
| Q3 | A question asked whilst completing the quality domain in the PQS declaration on MYS | string | Do you declare that by the end of 31 March 2023 you will be able to demonstrate all of the following? You actively identify and manage the risks at premises level associated with LASA and other high-risk medicines. You have put in place actions to prevent these risks. All actions identified in the patient safety report have been implemented. Answers: yes / no Mandatory |